The replicability of oncolytic virus: defining conditions in tumor virotherapy

From MaRDI portal
Publication:1942491

DOI10.3934/mbe.2011.8.841zbMath1259.34029OpenAlexW2330105388WikidataQ45365697 ScholiaQ45365697MaRDI QIDQ1942491

Jianjun Paul Tian

Publication date: 19 March 2013

Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.3934/mbe.2011.8.841




Related Items (22)

Modeling dynamics of cancer radiovirotherapyBifurcations and multistability in a virotherapy model with two time delaysHopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. IIMathematical and computational modeling for tumor virotherapy with mediated immunityHopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. IDynamics of immunotherapy antitumor models with impulsive control strategyOn a three-dimensional and two four-dimensional oncolytic viro-therapy modelsAnalysis of a delayed and diffusive oncolytic M1 virotherapy model with immune responseUltimate tumor dynamics and eradication using oncolytic virotherapyThe role of the innate immune system in oncolytic virotherapyModelling the spatiotemporal dynamics of chemovirotherapy cancer treatmentBackward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effectsThe role of viral infectivity in oncolytic virotherapy outcomes: a mathematical studyEnhancement of chemotherapy using oncolytic virotherapy: mathematical and optimal control analysisSpatial model for oncolytic virotherapy with lytic cycle delayMathematical analysis of a mathematical model of chemovirotherapy: effect of drug infusion methodGlobal dynamics of reaction-diffusion oncolytic M1 virotherapy with immune responseA mathematical model for oncolytic virus spread using the telegraph equationDeterministic and stochastic modeling for PDGF-driven gliomas reveals a classification of gliomasA combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-conceptAnalysis of a multiple delays model for treatment of cancer with oncolytic virotherapyBifurcation analysis of the cancer virotherapy system with time delay and diffusion




This page was built for publication: The replicability of oncolytic virus: defining conditions in tumor virotherapy